BGB-11417-201
Active, not recruiting
Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma
BeOne Study ID 
BGB-11417-201
ClinicalTrials.gov ID
EudraCT Number
2022-500687-35-00
China Drug Trials ID
CTR20221815
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents